SFM
YMAB

Sphera Funds Management’s Y-mAbs Therapeutics YMAB Stock Holding History

Sphera Funds Management’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-131,016
Closed -$6.49M – 205
2020
Q4 		$6.49M Sell
131,016
-265,505
-67% -$12.3M 0.58% 55
2020
Q3 		$15.2M Buy
396,521
+114,269
+40% +$4.55M 1.5% 16
2020
Q2 		$12.2M Sell
282,252
-25,127
-8% -$950K 1.15% 22
2020
Q1 		$8.02M Buy
307,379
+94,086
+44% +$2.73M 1% 23
2019
Q4 		$6.67M Buy
213,293
+23,293
+12% +$689K 0.55% 41
2019
Q3 		$4.95M Hold
190,000
– – 0.76% 42
2019
Q2 		$4.34M Buy
+190,000
New +$4.36M 0.59% 52

Other funds holding YMAB

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Sphera Funds Management's YMAB Position: Q1 2021 in Review

Sphera Funds Management sold out of Y-mAbs Therapeutics (YMAB) in Q1 2021, closing a stake of 131,016 shares — an estimated $6.49M sold.

Sphera Funds Management first reported a position in YMAB in Q2 2019 and held it in 7 quarters. The position peaked at $15.2M in Q3 2020. 117 funds tracked by Wall St. Rank hold YMAB as of Q1 2021.

  • Sphera Funds Management reported no remaining Y-mAbs Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Sphera Funds Management sold 131,016 Y-mAbs Therapeutics shares in Q1 2021, an estimated $6.49M.
  • Sphera Funds Management first reported a position in Y-mAbs Therapeutics in Q2 2019 and held it in 7 quarters.
  • Sphera Funds Management's Y-mAbs Therapeutics position peaked at $15.2M in Q3 2020.
  • 117 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q1 2021.

Based on Sphera Funds Management's 13F filing for Q1 2021, filed 17 May 2021.